Related Posts
- HER2-low vs HER2-negative MBC: Improved Survival
KEY TAKEAWAYS The study aimed to investigate features and outcomes of HER2-negative and HER2-low MBC…
- Low MSH-2: A Predictor of Poor Cervical Cancer Survival
KEY TAKEAWAYS The study aimed to define the prevalence of MMR-D and assess the predictive…
- Vedolizumab Improves Lower GI aGvHD-free Survival After Allo-HSCT
KEY TAKEAWAYS This phase 3 trial studied the efficacy and safety of Vedolizumab (VDZ) compared…